Prolonged transfer of feces from the lean mice modulates gut microbiota in obese mice
© The Author(s). 2016
Received: 13 June 2016
Accepted: 16 August 2016
Published: 23 August 2016
Transplanting a fecal sample from lean, healthy donors to obese recipients has been shown to improve metabolic syndrome symptoms. We therefore examined the gut microbiota in mice after administering a long-term, high-fat diet (HFD) supplemented with feces from lean mice through the fecal-oral route.
C57BL6/W mice were allowed to adapt to a non-specific pathogen free (SFP) environment for 2 weeks before being divided into three groups of 16 animals. Animals were fed for 28 weeks with a normal diet (ND), HFD or HFD supplemented with feces from ND-fed mice (HFDS). The composition of colonizing bacteria was evaluated in droppings collected under SPF conditions at the beginning of the study and at 12 and 28 weeks using an 16S Metagenomics Kit on Ion PGM sequencer.
HFD and HFDS-fed mice attained (p < 0.05) greater body weights by weeks 6 and 5, respectively. HFDS-fed mice gained more weight than HFD-fed mice by week 25. Both species diversity and richness indices increased with time in HFDS mice only.
Prolonged HFD-fed mice supplementation with feces from lean mice altered bacteria species diversity and richness, accelerated the onset of obesity, and caused increased weight gain in the later weeks of the HFD regimen.
Keywords16S rRNA sequencing Feces transplantation Gut microbiota High fat diet Obesity
Obesity results from an imbalance between energy intake and energy utilization. Obesity in both humans and animals is associated with decreased intestinal barrier function, gut inflammation and metabolic endotoxemia that can lead to systemic oxidative stress and chronic low-grade inflammation [1, 2]. Although the mouse and human gut metagenomes are similar at the phylum level, they reveal differences on the species level . However, because of the similarity of human and mice gut microbiota at the functional level , rodent diet-induced obesity is an accepted model for studying the behavioral and metabolic consequences of overnutrition.
The symbiotic relationship between commensal bacteria and the gut epithelial and lymphoid tissues gives rise to both innate and adaptive immune defenses to pathogens and anoxious antigens, facilitates dietary nutrient and energy harvesting, and enables fermentation of carbohydrates not otherwise digestible by the human host . The composition of the human gut microbiome changes within 24 h of initiating a high-fat (HF)/low-fiber or low-fat/high-fiber diet . The Bacteroides enterotype is most prevalent in animals exposed long-term to diets rich in protein and fat, while the Prevotella enterotype is most prevalent in animals exposed to diets rich in carbohydrates and deficient of protein . This parallels the microbiome composition observed in European children on a Western diet versus that seen in children in Burkina Faso living on a high-carbohydrate, low protein diet .
While in both humans and mice, the relative proportion of fecal Bacteroidetes may be lower and that of Firmicutes may be higher in obese individuals [2, 8], the meta-analysis has shown that these differences do not represent a consistent feature distinguishing lean from obese human gut microbiota . Obese-prone rats have a gut microbiota that is distinct from that of obese-resistant rats fed the same HF diet . The obese microbiome has a greater capacity to harvest energy; colonization of germ-free mice with microbiota from obese mice results in significantly more total body fat than does colonization with microbiota from lean animals, all else equal . Also, transfer of microbiota from obese-prone, but not obese-resistant rats, to germ-free mice replicates the obese-prone phenotype . Although obesity-related dysbiosis is functionally similar in humans and mice , altering the microbiota with probiotics, prebiotics and antibiotics causes weight loss only in mice, not humans .
Recent advances in bacterial culture-independent approaches facilitate investigation of the diversity, complexity and between-host variability of normal and disease-modified gut microbial communities. In this study, we examined the modifications of the intestinal microbial community under long-term exposure to a HF diet using 16S ribosomal RNA (rRNA) gene sequencing of DNA  extracted from fecal samples. In addition, we compared the gut microbial profiles of obese mice receiving supplementation of feces from lean mice through the fecal-oral route to profiles of control and obese mice over periods of 12 and 28 weeks.
Forty-eight 12-week-old male C57BL6/W mice were transferred to a non-SPF breeding facility and given 2 weeks to acclimate, during which time all animals were fed the standard diet (normal diet [ND]; 10 % of calories from fat) containing 22 % protein and 4.4 % fat (Labofeed H, Morawski, Poland). Animals were then randomly divided into three groups of 16 mice. Two experimental groups were fed a high-fat diet (HFD) containing 22 % protein and 30 % fat (Morawski, Poland), while the control group was fed ND. The diets of mice in one HFD group were supplemented with feces (HFDS) excreted by mice fed ND. Mice are coprophagic and, therefore, five fecal droppings per recipient mouse were added to the cage every week. Each animal was weighed weekly to an accuracy of 0.1 g. Every 4 weeks, each animal was placed into a metabolic cage with full access to feed and water for 24 h. The feces were collected and stored at −80 °C until use. After 28 weeks, mice were weighed and sacrificed. Blood samples were taken immediately afterwards.
C57BL6/W mice were born in a specific pathogen free (SPF) core facility at the Cancer Center Institute, Warsaw and maintained under standard conditions of humidity (55 ± 10 %) and temperature (21 ± 2 °C) in climate-controlled rooms under a 12-h light cycle. Animals had unrestricted access to water and food throughout the experiment. Animals were tested for the presence of viruses, bacteria and parasites according to the recommendations of the Federation of European Laboratory Animal Science Associations (FELASA).
Serum biochemical measures
Levels of serum glucose, cholesterol, alanine aminotransferase (ALT), aspartate aminotransferase (AST) and alkaline phosphatase (ALKP) were determined by spectrometry on a VITROS DT60-II system (modules DT, DTE, DTSC) using ready-to-use slides (Ortho-Clinical Diagnostics, Johnson & Johnson, Raritan, NJ, USA).
DNA extraction and metagenome sequencing
Approximately 200 mg of fecal droppings were overlaid with 1 mL InhibitEX Buffer and vortexed thoroughly until homogenized. The sample was then heated at 95 °C for 5 min followed by centrifugation at 14,000 rpm for 2 min using a MiniSpin Plus centrifuge (Eppendorf; Hamburg, Germany) to pellet the stool particles. A sample of the supernatant (200 μL) was transferred into a fresh tube, mixed with 15 μL Proteinase K and 200 μL of AL buffer, and incubated at 70 °C for 10 min. Subsequently, 200 μL of ethanol was added to the sample before transferring to a QIAamp spin column to isolate DNA following the QIAamp DNA Stool Kit protocol (Qiagen, Hilden, Germany). The isolated DNA was quantified with a Nanodrop spectrophotometer (Thermo-Fisher; Waltham, MA, USA) and stored in EB buffer at −20 °C until further analysis.
16S rRNA sequencing
Sequencing was performed on an Ion Torrent Personal Genome Machine (PGM) platform (Life Technologies; Carlsbad, CA, USA) using the Ion 16S Metagenomics Kit (Life Technologies; Carlsbad, CA, USA), as previously described . Deep sequencing data have been deposited at The European Bioinformatics Institute (EBI) Metagenomics repository under accession number PRJEB13279.
Bacterial taxonomic identification
Unmapped bam files were converted to fastq using Picard’s SamToFastq. Additional steps of the analysis were performed using Mothur software . Fastq files were converted into the fasta format. For analyses, we only kept sequences that were between 200 and 300 bases in length, had an average base quality of 20 in a sliding window of 50 bases, and had a maximum homopolymer length of 10. Chimeric sequences were identified with the UCHIME algorithm  using default parameters and our sequence collection as the reference database. Chimeric sequences were then removed. The remaining 16S rRNA sequences were classified using the Wang method and the SILVA bacterial 16S rRNA database for reference (release 102), at an 80 % bootstrap cut-off (Additional file 1: Table S1). Rarefraction curves on family level were drawn with MEGAN5 software . The taxonomic profile was created using a modified script from STAMP . In determining taxonomic profile, all hypervariable regions were taken into account since, as we previously described, it reflects better the contents of the sample .
Statistical analysis of differences in weight and biochemical parameters
Differences between weights in groups, as well as differences in biochemical parameters, were assessed with Student’s t-tests.
Data visualization and statistical analyses of taxonomy
Data visualization, statistical analyses and principal component analysis (PCA) were performed using R and the graphics package ggplot2 . Differences in the first two principal components between groups were evaluated with Mann-Whitney U-tests, or, in the case of paired samples, with Mann-Whitney paired U-tests. For statistical analyses on a taxonomical level, the relative abundance of each operational taxonomic unit (OTU) was computed as the number of sequences ascribed to a given OTU divided by the total number of good quality sequences in a sample. OTUs demonstrating essentially constant abundance (IQR < 0) were removed from taxonomic analyses. Differences between groups were evaluated with Mann-Whitney U-tests. Differences in the Bacteroidetes/Firmicutes ratio were determined in the same manner. Changes in taxa abundance over time were evaluated with linear mixed-effects models (using R package lme4) . Three models were considered: a null model (abundance ~ 1 + 1|mice), a model with time as the only covariate (abundance ~ 1 + time + 1|mice), and a model including the interaction of diet and time (abundance ~ 1 + time*diet + 1|mice). Models were compared with likelihood ratio tests. All p-values were corrected for multiple hypothesis testing using the Benjamini–Hochberg procedure to minimize the false discovery rate (FDR) .
Analysis of diversity
The Chao1 index of species richness and the Simpson index of community diversity were computed in Mothur . Differences between groups at the same time point were assessed with Student’s t-test. Differences between time points were assessed with Student’s paired t-test. Presented calculations are for level 5 of SILVA taxonomy.
Detailed descriptions of the biochemical measures are included in Additional file 1: Table S2. Relative to ND-fed mice, both HFD (p = 0.036) and HFDS-fed mice (p = 0.0019) developed hypercholesterolemia. Cholesterol level tended to be higher in HFDS than in HFD-fed mice (p = 0.056). Mean serum alkaline phosphatase level was lower in HFD-fed mice than in ND-fed mice (p = 0.0043). The mean levels of aspartate transaminase, alanine transaminase and glucose did not significantly differ between groups.
On average, 8.16 × 104 sequences were generated per library that passed all of the quality filters, and a total of 1.5748596 × 107 good quality sequence reads were generated and assigned to Bacteria or Archaea in the SILVA database. The sequencing depth was deemed to be sufficient with the use of rarefraction curves (Additional file 2: Figure S1). Using SILVA taxonomy, sequences from experimental mice were sorted into 339, 331 and 400 taxa in weeks 0, 14 and 28, respectively. Of these taxa, 57, 73 and 73 in each time point were represented in more than 0.01 % of the reads. Sequences for mice living in the SPF environment sorted into 227 taxa, 68 of which were present in more than 0.01 % of reads. The most abundant phyla found in mice living in the SPF facility were Bacteriodetes, Firmicutes and Proteobacteria (70.6 %, 22.5 %, and 4.8 %) and the proportions of these phyla were similar in experimental animals kept for 2 weeks in non-SPF conditions (week 0: 67.7 %, 28.8 % and 1.5 %). In week 0, Bacteroidetes/Firmicutes ratios in SPF mice (median, 4.94) and non-SPF mice (median, 3.38) did not differ (p-value = 0.1195 in Mann-Whitney U-test). Between weeks 0 and 12, the proportion of Firmicutes increased significantly and the proportion of Bacteroidetes decreased significantly in all three study groups. Median ratios for ND, HFD and HFDS-fed mice were 1.36, 1.85 and 1.73, respectively (p-values: 0.00015, 0.0076 and 0.00042). The ratios did not change further beyond week 12 within or between any of the three groups.
Taxa exhibiting differential abundances (relative to control mice; Mann-Whitney U-test) at 12 and 28 weeks of the experiment in high fat diet (HFD) fed mice and HFD-fed mice supplemented with feces (HFDS)
While a normal gut microbiota is recognized to contribute to human health, its disruption (dysbiosis) because of environmental exposures leads to numerous disorders, including obesity and obesity-linked co-morbidities . The relatively stable composition of the gut microbiome is modulated by many factors, including diet, sanitation, antibiotics and age . Most alterations of the microbiome’s composition are reversible . In animals, but not humans, altering the microbiota can modulate body weight. The transfer of microbiota from obese animals to germ-free and lean animals results in obesity, while the opposite is observed after introducing microbiota from lean animals to obese animals . However, the lack of intestinal microbiota may not protect mice from diet-induced obesity . Furthermore, although obesity has been associated with phylum-level changes in microbiota composition, reduced bacterial diversity and altered representation of bacterial genes and metabolic pathways, another study reported a lack of a correlation with the proportion of the phyla that were energy harvesters  The microbiota may adapt to diet over time, representing a consequence rather than a cause of obesity [8, 11]. Thus, the role of the gut microbiome in the control of body weight and energy homeostasis needs to be further studied.
In line with previous results , we found that the mouse gut microbiome was comprised primarily of Bacteriodetes (68.5 %), Firmicutes (27.8 %) and Proteobacteria (1.7 %). These are also the most abundant phyla in the human gut microbiome. Although species diversity and richness were not affected by obesity, the abundances of six families (Erysipelotrichaceae, Clostridiaceae, Verrucomicrobiaceae, Bifidobacteriaceae, Lactobacillales and Anaeroplasmataceae) were substantially different between lean and obese mice. Among these bacterial taxa, Erysipelotrichaceae and Clostridiaceae were especially enriched in HFD and HFDS-fed mice, while the abundance of Verrucomicrobiaceae was reduced in both groups of obese mice. All of these obesity-induced modifications of the gut microbial profile have been described previously.
Obesity is associated with changes in the relative abundance of the two dominant bacterial divisions, the Bacteroidetes and the Firmicutes [4, 24]. While some studies describe an increased ratio of Firmicutes to Bacteroidetes, other studies show none or even opposite trends . The proportion of gut Firmicutes increased under HFD mainly because of the proliferation of the immunogenic bacterial family Erysipelotrichaceae . A relatively higher abundance of Erysipelotrichaceae has been observed in both obese humans and animals [22, 25], while a lower abundance has been associated with reductions in mice liver injury and intestinal inflammation . In Crohn’s disease patients on low-fat enteral nutrition therapy, the abundance of Erysipelotrichaceae is decreased . Erysipelotrichaceae abundance has also been correlated with host cholesterol metabolites .
Akkermansia muciniphila produces a variety of fermentation products that may serve as energy sources for other bacteria and the host . In agreement with earlier studies conducted in genetically and diet-induced obese mice , the abundance of Verrucomicrobiaceae (including A. muciniphila, a mucin-degrading bacterium) was significantly decreased in both obese groups of mice. In humans, A. muciniphila was proposed to be a contributor to the maintenance of gut health and glucose homoeostasis, and it has been associated with a healthier metabolic status and better clinical outcomes after calorie restriction in obese adults . Consistent with these observations, treatment of obese mice with A. muciniphila reversed weight gain, metabolic endotoxemia and insulin resistance .
Fecal transplantation in animals has improved obesity, inflammation, insulin resistance and diabetes . While fecal microbiota transplant is an effective therapy for recurrent Clostridium difficile infection in humans (CDI) , only one short study of 18 obese men with metabolic syndrome revealed a beneficial effect of the infusion of microbiota from lean donors . On the other hand, development of new-onset obesity was recently reported in a woman treated for CDI with a transplant of feces from a healthy but overweight donor .
Mice are normally coprophagic and when lean and obese mice were housed in the same cage, the obese mice were protected from further weight gain by consuming microbiota from lean mice. However, the opposite effect, weight gain in lean mice eating feces from obese mice, was not observed . One hypothesis attributes this observation to differences between lean and obese mice in microbiome diversity that allow the transplantation of the lean microbiome to obese mice, but not vice versa . However, while increased α-diversity and decreased β-diversity after exposure to HFD have been reported , we did not observe significant HFD-related changes in species diversity (as measured by Simpson’s index) or in species richness (as measured by Chao1). By contrast, we observed a progressive, statistically significant increase in the both species diversity and richness in HFDS-fed mice (Fig. 5). Specifically, the abundance of 2 (ND), 3 (HFD) and 22 (HFDS) unique taxa differed significantly (adjusted p-values ≤ 0.05) between weeks 0 and 12, while 6, 11 and 20 taxa differed by week 28. Prolonged (lasting for 28 weeks) transferring of the gut microbiome from lean mice to HFD-fed mice through the fecal-oral route not only altered species diversity and richness, but also accelerated the onset of obesity. HFDS-fed mice gained more body weight in the last 4 weeks of feeding. Finally, hypercholesterolemia also tended to be more prevalent in HFDS-fed mice.
Abundances of three taxa (Peptococcaceae, Thermoanaerobacteraceae and Peptostreptococcaceae) appeared to increase significantly with fecal transplants from lean mice to HFD-induced obese mice (Table 1). A high-calorie diet has been associated with an increase in Peptostreptococcaceae , while an anti-obesity effect of vancomycin treatment in mice on HFD decreased the relative abundances of Peptostrepococcaceae and Peptococcaceae, both members of the phylum Firmicutes . In addition, dietary intervention with a β-glucan–producing, probiotic lactobacilli strain lowered the proportional abundance of Peptococcaceae as compared with the placebo group . Conversely, cellulose supplementation in mice with dextran sulfate sodium (DSS)-induced colitis increased the abundance of Peptostreptococcaceae . To date, no association between obesity and the relative abundance of Thermoanaerobacteraceae has been described.
As expected, housing conditions markedly influenced the composition of the microbiota in mice (this study and reviewed in ) and intestinal barrier integrity in mice fed a HFD . Future studies should consider environmental conditions to be one of the most important factors affecting the composition of the mouse gut microbiome.
In contrast to previous reports indicating that obesity-related changes of the gut microbiota take place at the phylum level , we found rather discrete obesity-related alterations of the mouse microbiome. Furthermore, our data demonstrate that, although transferring feces from lean to HFD-induced obese mice modified the composition of the gut microbiota, this was associated with weight gain instead of the expected weight reduction. These results suggest that there is an unknown compensatory effect that may upend the rationale for treating obesity through microbiota replacement. There is a critical need to search for specific gut microbiota compositions that could be used as therapeutic microbiota transplants.
The National Science Center, grant number 2011/03/B/NZ5/01511, recipient JO.
Availability of data and materials
The dataset supporting the conclusions of this article is available in the The European Bioinformatics Institute (EBI) Metagenomics repository under accession number PRJEB13279 (http://www.ebi.ac.uk/ena/data/view/PRJEB13279).
JO has conceived and supervised the study; KP, UK and MG have carried out experiment on animals; AP, NZB, FA and MKopczynski isolated DNA, prepared DNA libraries and performed sequencing, MKulecka has performed sequencing analyses and statistical analyses; JO, MKulecka and MM have written the manuscript. All authors read and approved the final manuscript.
The authors declare that they have no competing interests.
Ethics approval and consent to participate
Experimental protocols were approved by The 2nd Local Ethical Committee for Animal Research in Warsaw, Poland (decision 50/2014 granted on April 15th 2014).
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- de La Serre CB, Ellis CL, Lee J, Hartman AL, Rutledge JC, Raybould HE. Propensity to high-fat diet-induced obesity in rats is associated with changes in the gut microbiota and gut inflammation. Am J Physiol Gastrointest Liver Physiol. 2010;299:G440–8.View ArticleGoogle Scholar
- Hamilton MK, Boudry G, Lemay DG, Raybould HE. Changes in intestinal barrier function and gut microbiota in high-fat diet-fed rats are dynamic and region dependent. Am J Physiol Gastrointest Liver Physiol. 2015;308:G840–51.View ArticlePubMedPubMed CentralGoogle Scholar
- Bleich A, Fox JG. The Mammalian Microbiome and Its Importance in Laboratory Animal Research. ILAR J. 2015;56:153–8.View ArticlePubMedGoogle Scholar
- Xiao L, Feng Q, Liang S, Sonne SB, Xia Z, Qiu X, et al. A catalog of the mouse gut metagenome. Nat Biotechnol. 2015;33:1103–8.View ArticlePubMedGoogle Scholar
- Turnbaugh PJ, Bäckhed F, Fulton L, Gordon JI. Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe. 2008;3:213–23.View ArticlePubMedPubMed CentralGoogle Scholar
- Wu GD, Chen J, Hoffmann C, Bittinger K, Chen Y-Y, Keilbaugh SA, et al. Linking long-term dietary patterns with gut microbial enterotypes. Science. 2011;334:105–8.View ArticlePubMedPubMed CentralGoogle Scholar
- De Filippo C, Cavalieri D, Di Paola M, Ramazzotti M, Poullet JB, Massart S, et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci U S A. 2010;107:14691–6.View ArticlePubMedPubMed CentralGoogle Scholar
- Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006;444:1027–31.View ArticlePubMedGoogle Scholar
- Walters WA, Xu Z, Knight R. Meta-analyses of human gut microbes associated with obesity and IBD. FEBS Lett. 2014;588:4223–33.View ArticlePubMedGoogle Scholar
- Duca FA, Sakar Y, Lepage P, Devime F, Langelier B, Doré J, et al. Replication of obesity and associated signaling pathways through transfer of microbiota from obese-prone rats. Diabetes. 2014;63:1624–36.View ArticlePubMedGoogle Scholar
- Bell DSH. Changes seen in gut bacteria content and distribution with obesity: causation or association? Postgrad Med. 2015;127:863–8.View ArticlePubMedGoogle Scholar
- Zeber-Lubecka N, Kulecka M, Ambrozkiewicz F, Paziewska A, Lechowicz M, Konopka E, et al. Effect of Saccharomyces boulardii and Mode of Delivery on the Early Development of the Gut Microbial Community in Preterm Infants. PLoS One. 2016;11:e0150306.View ArticlePubMedPubMed CentralGoogle Scholar
- Schloss PD, Westcott SL, Ryabin T, Hall JR, Hartmann M, Hollister EB, et al. Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl Environ Microbiol. 2009;75:7537–41.View ArticlePubMedPubMed CentralGoogle Scholar
- Edgar RC, Haas BJ, Clemente JC, Quince C, Knight R. UCHIME improves sensitivity and speed of chimera detection. Bioinformatics. 2011;27:2194–200.View ArticlePubMedPubMed CentralGoogle Scholar
- Huson DH, Mitra S, Ruscheweyh H-J, Weber N, Schuster SC. Integrative analysis of environmental sequences using MEGAN4. Genome Res. 2011;21:1552–60.View ArticlePubMedPubMed CentralGoogle Scholar
- Parks DH, Tyson GW, Hugenholtz P, Beiko RG. STAMP: statistical analysis of taxonomic and functional profiles. Bioinformatics. 2014;30:3123–4.View ArticlePubMedPubMed CentralGoogle Scholar
- Wickham H. ggplot2: Elegant Graphics for Data Analysis. 1st ed. 2009. Corr. 3rd printing 2010 edition. New York: Springer; 2010.Google Scholar
- Winter B. Linear models and linear mixed effects models in R with linguistic applications. arXiv:1308.5499 [cs] [Internet]. 2013 [cited 2016 Mar 14]; Available from: http://arxiv.org/abs/1308.5499
- Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B Methodol. 1995;57:289–300.Google Scholar
- Alcock J, Maley CC, Aktipis CA. Is eating behavior manipulated by the gastrointestinal microbiota? Evolutionary pressures and potential mechanisms. Bioessays. 2014;36:940–9.View ArticlePubMedPubMed CentralGoogle Scholar
- Carmody RN, Gerber GK, Luevano JM, Gatti DM, Somes L, Svenson KL, et al. Diet dominates host genotype in shaping the murine gut microbiota. Cell Host Microbe. 2015;17:72–84.View ArticlePubMedGoogle Scholar
- Fleissner CK, Huebel N, Abd El-Bary MM, Loh G, Klaus S, Blaut M. Absence of intestinal microbiota does not protect mice from diet-induced obesity. Br J Nutr. 2010;104:919–29.View ArticlePubMedGoogle Scholar
- Murphy EF, Cotter PD, Healy S, Marques TM, O’Sullivan O, Fouhy F, et al. Composition and energy harvesting capacity of the gut microbiota: relationship to diet, obesity and time in mouse models. Gut. 2010;59:1635–42.View ArticlePubMedGoogle Scholar
- Parks BW, Nam E, Org E, Kostem E, Norheim F, Hui ST, et al. Genetic control of obesity and gut microbiota composition in response to high-fat, high-sucrose diet in mice. Cell Metab. 2013;17:141–52.View ArticlePubMedPubMed CentralGoogle Scholar
- Zhang H, DiBaise JK, Zuccolo A, Kudrna D, Braidotti M, Yu Y, et al. Human gut microbiota in obesity and after gastric bypass. Proc Natl Acad Sci U S A. 2009;106:2365–70.View ArticlePubMedPubMed CentralGoogle Scholar
- Harris JK, El Kasmi KC, Anderson AL, Devereaux MW, Fillon SA, Robertson CE, et al. Specific microbiome changes in a mouse model of parenteral nutrition associated liver injury and intestinal inflammation. PLoS One. 2014;9:e110396.View ArticlePubMedPubMed CentralGoogle Scholar
- Kaakoush NO. Insights into the Role of Erysipelotrichaceae in the Human Host. Front Cell Infect Microbiol. 2015;5:84.View ArticlePubMedPubMed CentralGoogle Scholar
- Martínez I, Perdicaro DJ, Brown AW, Hammons S, Carden TJ, Carr TP, et al. Diet-induced alterations of host cholesterol metabolism are likely to affect the gut microbiota composition in hamsters. Appl Environ Microbiol. 2013;79:516–24.View ArticlePubMedPubMed CentralGoogle Scholar
- Dao MC, Everard A, Aron-Wisnewsky J, Sokolovska N, Prifti E, Verger EO, et al. Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology. Gut. 2016;65:426–36.View ArticlePubMedGoogle Scholar
- Stenman LK, Burcelin R, Lahtinen S. Establishing a causal link between gut microbes, body weight gain and glucose metabolism in humans - towards treatment with probiotics. Benef Microbes. 2015;1–12. [Epub ahead of print].Google Scholar
- Joyce SA, Gahan CGM. The gut microbiota and the metabolic health of the host. Curr Opin Gastroenterol. 2014;30:120–7.View ArticlePubMedGoogle Scholar
- Lapointe-Shaw L, Tran KL, Coyte PC, Hancock-Howard RL, Powis J, Poutanen SM, et al. Cost-Effectiveness Analysis of Six Strategies to Treat Recurrent Clostridium difficile Infection. PLoS One. 2016;11:e0149521.View ArticlePubMedPubMed CentralGoogle Scholar
- Vrieze A, Van Nood E, Holleman F, Salojärvi J, Kootte RS, Bartelsman JFWM, et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology. 2012;143:913–6. e7.View ArticlePubMedGoogle Scholar
- Alang N, Kelly CR. Weight gain after fecal microbiota transplantation. Open Forum Infect Dis. 2015;2:ofv004.View ArticlePubMedPubMed CentralGoogle Scholar
- Matsushita N, Osaka T, Haruta I, Ueshiba H, Yanagisawa N, Omori-Miyake M, et al. Effect of lipopolysaccharide on the Progression of non-alcoholic fatty liver disease in high caloric diet-fed mice. Scand J Immunol. 2016;83:109–18.View ArticlePubMedGoogle Scholar
- Clarke SF, Murphy EF, O’Sullivan O, Ross RP, O’Toole PW, Shanahan F, et al. Targeting the microbiota to address diet-induced obesity: a time dependent challenge. PLoS One. 2013;8:e65790.View ArticlePubMedPubMed CentralGoogle Scholar
- London LEE, Kumar AHS, Wall R, Casey PG, O’Sullivan O, Shanahan F, et al. Exopolysaccharide-producing probiotic Lactobacilli reduce serum cholesterol and modify enteric microbiota in ApoE-deficient mice. J Nutr. 2014;144:1956–62.View ArticlePubMedGoogle Scholar
- Nagy-Szakal D, Hollister EB, Luna RA, Szigeti R, Tatevian N, Smith CW, et al. Cellulose supplementation early in life ameliorates colitis in adult mice. PLoS One. 2013;8:e56685.View ArticlePubMedPubMed CentralGoogle Scholar
- Hansen AK, Krych Ł, Nielsen DS, Hansen CHF. A review of applied aspects of dealing with gut microbiota impact on rodent models. ILAR J. 2015;56:250–64.View ArticlePubMedGoogle Scholar
- Müller VM, Zietek T, Rohm F, Fiamoncini J, Lagkouvardos I, Haller D, et al. Gut barrier impairment by high-fat diet in mice depends on housing conditions. Mol Nutr Food Res. 2015;60(4):897–908.View ArticleGoogle Scholar
- Villanueva-Millán MJ, Pérez-Matute P, Oteo JA. Gut microbiota: a key player in health and disease. A review focused on obesity. J Physiol Biochem. 2015;71:509–25.View ArticlePubMedGoogle Scholar